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Abstract
Headache is the most frequent neurological symptom and the most prevalent pain in children and adolescents,
and constitutes a serious health problem that may lead to impairment in several areas. Psychosocial factors, social
environment, life events, school and family stressors are all closely related to headaches. A multidisciplinary strategy
is fundamental in addressing headache in children and adolescents. Applying such a strategy can lead to reductions in
frequency and severity of the pain, improving significantly the quality of life of these children.
It has been demonstrated that behavioral intervention is highly effective, especially in the treatment of paediatric
headache, and can enhance or replace pharmacotherapy, with the advantage of eliminating dangerous side effects
and or reducing costs. Behavioral interventions appear to maximize long-term therapeutic benefits and improve
compliance with pharmacological treatment, which has proven a significant problem with child and adolescent with
headache.
The goal of this review is to examine the existing literature on behavioral therapies used to treat headache in children
and adolescents, and so provide an up-to-date picture of what behavioral therapy is and what its effectiveness is.
Keywords: Headache, Behavioral therapies, Non-pharmacological therapies, Cognitive behavioral therapy, Children,
Adolescents
Abbreviations: CBT, Cognitive-behavioral therapy; CM, Chronic migraine; GI, Guided imagery; MA, Migraine with aura;
PMR, Progressive muscle relaxation
Introduction
Headache affects about 60 % of children and adolescents
all over the world. Tension type headache (prevalence of
20–25 %) is the most common cause of primary head-
ache, followed by migraine (prevalence of 8 %) [1]. From
epidemiology, it is clear that the onset of primary head-
ache is often in childhood or adolescence [2] and the
prevalence grows with children’s age. Research shows
that children, adolescents and adults with headache do
not seek medical care for their headaches and nearly half
never receive a diagnosis [3].
Headache can affect all aspects of a child’s functioning.
It has been associated with psychiatric illness, such as
anxiety and depression, as well as psychosocial problems
(e.g. school absences, problematic social interactions)
[4, 5]. Recognizing anxiety, depressive symptoms and
other psychiatric disorders should be considered in
the clinical assessment of headache patients, especially
in children and adolescents, as early identification of
these symptoms may lead to improved headache
management [6]. Furthermore the comorbidity with
affective disorders and psychopathology in general
may also enhance suicidal risk in migraine patients,
especially in children and adolescent population, with
a significant impact on public health [7]. Some stud-
ies investigated the gene-environment interaction and
other risk factors involved in suicidal behaviour in
headache patients [8, 9] showing that shared mechan-
ism could be implicated in the pathophysiology of
both migraine and affective disorders.
Furthermore an excessive use of medication in chil-
dren and adolescents, and its association with certain
undesirable behaviors or lifestyles, suggest educational
initiatives on drug use are an important part of treat-
ment [10]. Some non-pharmacological therapies seem to
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have effects that are similar to those of most drugs used
for the prevention of migraine and tension-type head-
aches. These therapies often do not have dangerous
adverse effects and are much less expensive than
pharmacological therapies both in children and adoles-
cents than in adults [11, 12].
An analysis of Mazzotta et al. [13] about the direct
and indirect costs of headache in childhood and adoles-
cence, indicates an overall cost of €18,614.30 for the
treatment of twenty-five patients (7–18 years). The total
direct cost is €17,290, of which 93 % covers visits and
diagnostic testing, and the remaining 7 % covers symp-
tomatic or prophylactic pharmacological therapy. The
average expense for each patient is €691.60. In consider-
ing the different types of headaches, the study shows
that the greatest expense is associated with Migraine
with aura (MA) patients (€802.80 per patient), followed
by chronic migraine (CM) patients (€760.50 per patient)
and finally headache secondary to sinusitis patients
(€692 per patient). The conclusion of the study of Maz-
zotta et al. [13] is that by combining effectiveness,
minimal side effects, and cost savings, behavioral inter-
ventions provide a treatment option that can enhance
or if necessary, replace pharmacotherapy.
Moreover, medications should generally not be pre-
scribed alone but rather in combination with non-
pharmacological therapies [14]. In addition, behavioral
therapy help maximize long-term therapeutic benefit
and ensure compliance with pharmacological treatment,
which has been proven a significant problem with head-
ache patients [15].
Review
Search strategy and selection criteria
We included the following search terms “headache” OR
“migraine” and related terms, AND “behavioral manage-
ment”, “behavioral treatment”, “behavioral therapy”,
“non-pharmacological treatments”, “psychiatric comor-
bidities”, “cognitive-behavioral therapy”, “treatment adher-
ence”, “psychological intervention”, “lifestyle habits” IN
“children”, “childhood”, “child”, “adolescents”, “adoles-
cence”, “young” and entered them into Pubmed databases.
We reviewed the reference lists of paper identified and in-
cluded articles judged as relevant. Highly regarded books
published and additional non-peer-reviewed literature
were included in this review, identified through a Google
search and from citations in several key articles. We did
our search between Sept 20, 2015, and June 15, 2016.
What is behavioral therapy?
Behavioral treatment strategies for pain management
have been researched intensively in recent years and are
mostly derived from cognitive-behavioral therapy (CBT)
[16] (Fig. 1). In migraine treatment, behavioral treatment
strategies have in many cases been shown to be as effect-
ive as pharmacological treatment [17], not only for head-
ache management, but also to maintain a lifetime
response to the headache treatment [15].
The American Academy of Neurology–U.S. Consortium
[18] noted that, given the presence of specific factors,
behavioral and other non-pharmacological treatment are
preferred to pharmacological treatment for migraine
headache. These factors are:
 patient preference for non-pharmacological
treatments;
 poor tolerance or poor response to pharmaceuticals;
 negative side effects of medication;
 actual or planned pregnancy;
 history of overuse of acute care medication;
 significant stress;
 inadequate ability to cope with stress or pain;
 comorbid psychological disorders [19]
In other words, individuals with clinical depression or
anxiety, those with moderate-to-severe headache-related
disabilities, those with difficulty managing triggers (in-
cluding stress) or with other significant psychological is-
sues (e.g., history of abuse/maltreatment), and those that
prefer behavioral approaches are all ideal candidates for
behavioral intervention [18, 20, 21].
The goals of behavioral treatments are to reduce the
frequency and severity of pain, increase the patients’
control of their headaches, reduce related disabilities
and symptoms, and limit reliance on poorly tolerated or
unwanted medications [22].
The behavioral approach maximizes adherence to the
prescribed headache treatment regimen, and incorpo-
rates the assessment of the impact of headache on a the
child or adolescent’s quality of life, disability, and emo-
tional functioning [23]. Non-adherence to prescribed
treatment is an important and widespread behavioral
health issue in the management of headache [24]. Poor
adherence to prescribed treatment regimens can com-
promise the efficacy of medical treatments, and the
health and quality of life of patients [25].
Behavioral therapy consists of three components [26]
(Fig. 2):
1) Treatment adherence;
2) Adjustment of lifestyle management;
3) Psychological intervention.
Treatment adherence
The first component involves educating the patient and
his or her parents about the importance of complying
with the assigned treatment, and identifying factors may
limit the effectiveness of the plan. Several studies
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support that non-adherence to treatment is an issue of
utmost importance in the treatment of headache; indeed
a good adherence to treatment has a positive impact on
disease severity, risk of relapse, greater health care
utilization, and sub optimal symptom management
[24, 25]. The literature about this topic in children
and adolescents is poor: to date a few studies have
investigated this factor in pediatric headache [27–30].
Non-adherence to headache treatment is estimated at
50–88 % among children and adolescence [24, 31].
Treatment non-adherence can affect not only the prog-
nosis of the disorder, with a worsening condition but
also the overall health care system with an increased
costs and an overuse of the health care system. Indeed
non adherence to treatment leads to poor outcomes,
which then increase service utilization and health care
cost [32]. The factors that may limit the adherence to
treatment can be divided in three categories: (1) regimen
characteristics (e.g. difficulty of lifestyle changes), (2) dis-
ease characteristics (e.g. younger age of onset, frequency
and severity of headache attacks), and (3) patient or fam-
ily characteristics (e.g., premorbid/comorbid behavioral,
psychopathology or dysfunctional family) [22, 33]. Fac-
tors that can have a positive effect on adherence are
positive family functioning, close friends, internal locus
of control, treatment with immediate benefits, and a
good collaboration between doctor and patient [34]. The
identification of needs, anxieties and expectations of the
patients and their families regarding the treatment, al-
lows the medical staff to monitor any possible preoccu-
pation and fear, so that the best migraine management
approach is administered to improve the quality of life
of children and adolescents [35]. Interventions can have
an educational, behavioral and clinical focus. Educational
strategies provide verbal and written instructions to pa-
tients and their parents about the management of head-
ache symptoms and the importance of the proposed
treatment [22]. Educating patients can help reduce the
helplessness and fear commonly experienced with mi-
graine, enabling them to take control, reduce acute
headache pain, and optimize long-term quality of life
[36, 37]. Visual reminders to cue behaviour, such as
charts for relaxation practice, alarms on watches or
phones, self-monitoring, and rewards for treatment
compliance are often used to help encourage adherent
behaviour [22]. In children and adolescents a useful
technique to remember is to pair a new behavior with a
behavior that is already well-established in daily routine,
such as brushing teeth [34]. Furthermore, a number of
emotional and behavioral problems can occur, that
Fig. 1 The behavioral therapy
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interfere with the success of a treatment. These cases re-
quire clinical intervention strategies to modify these be-
havioural and emotional difficulties. All the obstacles,
fears, anxieties and troubles that patients meet along the
way, must be identified and addressed in the plan.
Adjustment of lifestyle habits
Lifestyle interventions are focused on the acquisition
and maintenance of healthy lifestyle habits [22]. Clini-
cians have the task of assisting children and their fam-
ilies in changing lifestyle habits, and of pointing out the
importance of this issue. Indeed, lifestyle habits have a
great influence on medical outcomes and changing un-
healthy habits and behaviours can significantly improve
quality of life [38]. There is evidence that unhealthy life-
style habits are a trigger for childhood headaches [22,
26]. Headache triggers are varied and may have different
results at different times, so it can be very difficult to
identify them. A headache diary can be a useful way to
keep headache attacks under control [39]. Headache
triggers often include stress, sleep disorders, weather,
lights, odours, sounds and specific foods [40–42].
The most common trigger was stress which was re-
ported by 75.5 % of patients [41]; sources of stress in
children and adolescents can include:
 school: new school or new teacher, tests and exams,
bullying, learning disabilities
Fig. 2 Behavioral management options
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 family: very permissive or very strict parents, a new
brother or sister, divorce, death of a family member.
 friends: very few friends, peers make fun of him/her.
Many studies show that there is a clear association be-
tween headache and sleep disorders [43, 44].
In sample of Neut D. et al., lack of sleep was reported
by 69.6 % of patients [41]. Children with headache re-
port more daytime symptoms of sleep disturbance in-
cluding fatigue, tiredness, and sleepiness [45]. Bruni et al.
[46] revealed that keeping a consistent bedtime and wak-
ing time, sleeping the same amount of hours every night,
ensuring that sleep is continuous without frequent awak-
ening, and restricting the intake of food and fluids prior to
sleeping reduced headache frequency and duration.
Another commonly reported headache trigger in chil-
dren are fluctuations in weather [40, 47]. Connelly et al.
[47], found that relative humidity and presence of pre-
cipitation were significantly predictive of new headache
onset in children and adolescents.
An abnormal sensitivity to or intolerance of light (photo-
phobia) is reported as a trigger by 52.9 % of children and
adolescents with headache [41]; a hypersensitivity to odours
(osmophobia) by 55 % and an intolerance or hypersensitiv-
ity to sound (phonophobia) by 47 % [48]. These diseases
affect mainly children with diagnosis of migraine than
tension-type headache, so the presence of these factors can
be a supportive diagnostic criterion for the differential diag-
nosis between migraine and tension-type headache [49].
Some foods can be a trigger for headache attacks,
maybe because they activate biochemical mechanisms
involved in headache disorder. For example, chocolate
was reported by 11.8 % and cheese by 3.9 % [41]. On the
other hand, the consumption of other food and drink
items was found to be beneficial [50]. Nutraceuticals, for
instance, can be effective in treating migraines in chil-
dren and adolescents [51]. Moreover, magnesium, ribo-
flavin, coenzyme Q10, the herbal extracts of butterbur,
feverfew, and ginkolide B have all been suggested as pre-
ventatives for migraine [52–55]. Research has indicate that
magnesium in migraine patients is significantly lower than
the normal population, and is related to the frequency of
migraine attacks, supporting the use of magnesium in pre-
vention and treatment of migraine [56]. Foods that are
high in magnesium include beans, fish, walnuts, rice, al-
monds, dark leafy greens, seeds, whole grains, avocados,
yoghurt, bananas and dark chocolate. Riboflavin (B2), act-
ing on mitochondrial metabolism, is shown to be effective
in the treatment of migraines, even if more research is
needed in children [57]. Coenzyme Q10 has demonstrated
the potential to modify inflammatory changes and alter-
ation of mitochondrial function that may occur during re-
current headaches [58]; foods that are also high in Q10
include cereals, nuts and vegetables. Combinations of
ginko, coenzyme Q10, riboflavin, and magnesium have
been studied in children and adolescents with migraine
with positive outcomes [52, 59].
Researchers at the City of London Migraine Clinic
found that feverfew a traditional medicinal herb, elimi-
nates about two-thirds of migraines in a selected group
of adult headache patients, which is similar to the effect-
iveness of most migraine drugs, [60] but to date there
are no trials that indicate the safety or efficacy of fever-
few for pediatric headache [61].
Oxidative stress, a disturbance in the balance between
the production of free radicals and antioxidant defenses
[62], plays a role in the development of paediatric migraine
[63], so it is important finding new therapeutic factors with
antioxidant properties for treatment of headache.
So there is evidence that lifestyle changes such as
healthy sleeping habits, good hygiene, diet free of food
additives are associated with a significantly lower fre-
quency of migraine attacks and shorter disease duration
for children and adolescents with migraine [64].
Psychological intervention
Psychological treatments are essential elements of the
multidisciplinary, bio-psychosocial management of primary
headache disorders, particularly for those with frequent or
chronic headache, a high level of headache-related disabil-
ity, medication overuse, or comorbid psychiatric symptoms
[65]. In children and adolescents, headache is commonly
associated with several psychiatric comorbidities, in par-
ticular depression, anxiety and attention-deficit/hyperactiv-
ity disorder [5]. Teaching relaxation techniques, stress
reduction, increasing physical activity, and other psycho-
logical interventions should be considered standard man-
agement options for children with headache and other
comorbidities [36]. Self-regulation strategies, such as relax-
ation and biofeedback, as well as cognitive behavior therap-
ies are reported as the most commonly used behavioral
treatments for headache [22, 66]. These treatments
emphasize the active involvement of patients and they aim
to change dysfunctional thoughts and maladaptive behav-
iors, in order to facilitate the use of effective strategies for
coping with pain, and to improve headache symptoms [67].
Active involvement of patients can lead to increased
confidence in abilities to prevent and manage headaches
[22, 68], which in turn can lead to less headache-related
disability [22, 69]. In management of primary headache,
psychological treatments include [65]:
 Relaxation skills;
 Biofeedback
 Cognitive behavioral therapy.
Relaxation skills are used to decrease headache by
enabling patients to modify their own headache-related
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physiological responses and decrease sympathetic
arousal [22, 70]. Techniques to reduce tension include:
progressive muscle relaxation (PMR), autogenic phrases,
self-hypnosis, guided imagery (GI), and diaphragmatic
breathing [71] (Table 1). These techniques have been
shown to be as effective as pharmacological treatment in
child, adolescent and adult, improving the frequency, in-
tensity, and duration of headache [72, 73].
Biofeedback refers to the use of electronic or electro-
mechanical tools to measure and then feed back informa-
tion about physiological functions and it is useful in
paediatric headache to understanding and addressing the
mind-body connection [22, 74]. Multiple published studies
have suggested that biofeedback is effective in reducing
the frequency and severity of headaches, often allowing
patients to decrease their dependence on medication [75].
Cognitive behavioral therapy is a treatment that targets
behaviours, emotions, and cognitions that trigger or aggra-
vate headaches [66]. CBT consists mainly of cognitive and
behavioral techniques and it helps the patient alter
thoughts, interpretations of events, assumptions, and typ-
ical behavioral patterns of responding to stressors or
events, increasing patient’s ability to cope with the pain
and to reduce headache-related distress [22]. Cognitive-
behavioral techniques, in particular, have been found to re-
duce the intensity and frequency of headache in children
and adolescents [76]. It is proposed that these competen-
cies could contribute to the successful long-term preven-
tion of an adverse course of headache into adulthood [77].
The Efficacy of Behavioral Intervention in children and
adolescence with headache
Behavioral interventions provide a treatment option that
can enhance or if necessary, replace pharmacotherapy.
The combination of both pharmacological and non-
pharmacological treatment has been shown to be super-
ior to each individually, and appears to maximize long-
term therapeutic benefit of treatment [78, 79]. During
the past several decades, it has become clear that all
mental processes derive from mechanisms of the brain
[80]. This means that any change in our psychological
processes is reflected by changes in the functions or
structures of the brain and there is clear evidence that
our subjective experiences affect the brain [81]. Psycho-
therapy provides the learning of new alternative ways of
thinking and behaving. This learning can bring change
in the brain by altering the strength of synaptic inter-
actions between neurons, thereby leading to real mor-
phological changes in the neurons themselves and
generating new conditions in the brain [82, 83].
Neuroimaging studies have found that psychotherapy
has measurable effects on the central nervous system:
psychotherapy may modify brain function and metabol-
ism in specific brain areas [84, 85]. Many psychother-
apies attempt to enhance patients’ problem-solving
capacities, self-representation, and regulation of affective
states [86]. The brain areas involved in these functions
are the dorsolateral prefrontal cortex, the ventral anter-
ior cingulate cortex, the dorsal anterior cingulate cortex,
the ventral and dorsal sub-regions of the medial pre-
frontal cortex, the posterior cingulate cortex, the precu-
neus, the insular cortex, the amygdala, and the
ventrolateral prefrontal cortex [87]. About twenty stud-
ies have been published on brain effects of psychological
treatments for obsessive compulsive disorder, anxiety
disorder (e.g. panic disorder and social phobia), schizo-
phrenia and depression. In this way it is possible to treat
the comorbidities present in subjects with headache and
thereby improve their quality of life.
Children with chronic physical illness are significantly
more likely to develop common psychiatric symptoms
than otherwise healthy children [88], and high levels of
psychological comorbidity [5] has led to migraine be-
coming more commonly viewed as a bio-psychosocial
condition, influenced by cognitive, emotional and envir-
onmental factors, as well as biological [89].
A recent systematic review about psychological inter-
ventions for mental health disorders in children with
chronic physical illness, in fact, shows that children may
benefit from cognitive behavioral interventions for de-
pression and anxiety in the context of a comorbid
chronic physical health problem [88].
A recent meta-analysis showed that psychological ther-
apies can significantly reduce pain and disability in
children and adolescents with chronic pain, and in par-
ticular headache pain [90]. Reviews using CBT on chil-
dren, adolescents and adult headache patients showed
reduction in migraine and tension-type headache attacks
in a pre-/post-treatment for intensity, frequency, and
duration of headache, significantly superior to control
conditions [11, 66, 91–93].
Power et al. [12] carried out a study to determine the
benefits of CBT in children and adolescents (aged 10–17)
with chronic migraine, when combined with amitriptyline
versus headache education plus amitriptyline. They find
that, in children and adolescents with chronic migraine,
the use of CBT plus amitriptyline is associated with greater
Table 1 Relaxation skills
Relaxation skill What is it?
Progressive muscle relaxation Series of relaxation exercises
Autogenic phrases Phrases focused on several parts of the
body (e.g. “my arms are heavy”)
Self-hypnosis Process of self-induced hypnosis
Guided imagery Patients must focus on image of peace
and serenity
Diaphragmatic breathing Patients learn to breath using diaphragm
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reductions in days with headache and migraine-related dis-
ability compared with use of headache education plus ami-
triptyline. These findings support the efficacy of CBT in
the treatment of chronic migraine in children and adoles-
cents. Chen YZ et al. [94] investigate the preventive effect
of behavioral therapy plus flunarizine in children with mi-
graine, and report that preventive treatment of behavioral
therapy plus oral flunarizine had better clinical efficacy
than oral flunarizine alone, in children with migraine.
Relaxation techniques, including PMR, autogenic
phrases, self-hypnosis, GI, and diaphragmatic breathing
has been shown to be an effective therapeutic approach for
the management of headaches in children and adolescents
[27, 95–99]. Trautmann et al. [100] found that relaxation,
biofeedback, and CBT are highly effective in treating head-
ache symptoms, both in frequency and severity. Relaxation
or biofeedback alone obtain improvement in about 50 %;
when combined about 60 % improvement was seen [101].
With CBT and biofeedback, improvement in children
with migraine reaches 75 % [102]. Blume et al., found
a positive response to biofeedback in 58 % and a 43
% reduction in headache days with biofeedback ther-
apy in children and adolescents with headache [103].
Meta-analytic findings of Palermo et al. demonstrated
a large positive effect of psychological intervention on
pain reduction at immediate post-treatment and follow-up
in youth with headache. It would appear that cognitive-
behavioral therapy, relaxation therapy, and biofeedback all
produced improvement in pain relief [104].
Fisher et al. [105] show the efficacy also of psychological
therapies delivered remotely, compared to waiting-list,
treatment-as-usual, or active control treatments, for the
management of chronic pain in children and adolescents.
Psychological therapy delivered remotely confirms benefit
in reducing the intensity or severity of pain in children.
Penzien et al. report [19] the following recommenda-
tions pertaining to behavioral interventions for migraine
(as they have been outlined by the US Headache
Consortium) [106]: (1) relaxation training, thermal bio-
feedback combined with relaxation training, electromyo-
graphic biofeedback, and cognitive behavioral therapy
are treatment options for prevention of migraine (grade A
evidence); and (2) behavioral therapy may be combined
with preventive drug therapy to achieve added clinical im-
provement for migraine (grade B evidence).
Further studies are needed to point out the exact
mechanisms of behavioral treatments [107] in children
and adolescents with primary headache, which are likely
multifactorial.
Limitations
Behavioral therapy like other forms of headache manage-
ment is imperfect [108], and some issues make it inad-
equate for some people (Table 2 Strengths and limitations):
1) Behavioral approaches give us an idea of how
individuals react to specific life situations, but
patterns of behaviour may vary over the course of
an individual’s life [108].
2) Although behavioral treatment is considered a short-
term therapy, it takes time to change same behaviours
and replace negative behaviours with positive ones.
Parents and teachers may find this frustrating.
3) Behavioral therapy has focused on the development
and study of specific effective techniques to address
different clinical situations; however, it sometimes
does not always take into account individual
differences that imply that these methods cannot be
applied in the same way to all subjects [108].
4) Behavioral therapy teaches individuals some skills for
coping with the problems (cognitive restructuring,
problem solving, relaxation), but teaching parents
skills to work more effectively with their children can
result in a poor compliance. A working relationship
between the patient and therapist is an essential part
of any psychotherapy and is crucial for patient’s
improvement [109].
5) In behavioral interventions the emphasis is on the
“here and now” [110], but sometimes it is necessary
to go back in time and explore the origin of the
disorder.
6) Behavioral therapists must recognize that they have
become embedded in a relationship with the patient,
so they must maintain a sense of awareness and
control over their own emotional reactions to the
patient’s behaviour [111].
7) CBT may not be effective for people with severe
mental disorders or for those with learning difficulties.
The focus of CBT is always on patients and their
capacity to bring change to themselves [112].
Table 2 Strengths and limitations
Strengths Limitations
Cost saving It takes time to change same
behaviors, so parents and teachers
may find this frustrating.
Ensure Compliance Teach parents how work more
effectively with their children can
result in a poor compliance
Maximize long term therapeutic
benefit
The focus is “here and now”
No negative side effects of
medications
Therapist must maintain a sense
of control and awareness
Learning of new alternative ways
of thinking and behaving
Patterns of behavior may change
over the course of life
Reduction of headache severity
and frequency
It is not effective for people with
severe mental disorder
Reduce pain and disability It does not always take into
account individual differences
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Behavioral headache interventions continue to face
significant challenges that in part derive from the inabil-
ity to conduct a truly double blind trial, and from
limited availability of behaviourally trained headache
clinicians [19, 113]. Rains in his review about the
“Behavioral Headache Treatment” [66] has presented
a critique of methodological quality of the clinical tri-
als literature, highlighting the strengths and weak-
nesses in relation to recruitment and selection of
patients, sample size and statistical power, the use of
a credible control, and the reproducibility of the
study interventions in clinical practice. There is a lit-
tle research on the effectiveness of behavioral head-
ache interventions in children and adolescence and
this topic has often been discussed rather than clinic-
ally investigated.
Conclusion
Headache is a common condition among children and
adolescents that has a large impact on school and other
areas of daily life, and more generally on the quality of
life of children and their families. Lacking proper care,
many children will continue to experience headaches
into adulthood. These considerations point to the im-
portance of prompt, effective, and early intervention for
paediatric headache [4].
Multidisciplinary treatment is an effective strategy
for children and adolescents and shows improvement
in multiple measures of outcome, including frequency
and severity of headache and number of school days
missed because of headache. Behavioral therapy is
very useful to such an intervention [114]. Attention
to the effects of headache, to needs and fears of chil-
dren and adolescents, and to factors that may limit
the effectiveness of the therapy, is an important part
of treatment.
Behavioral therapy may reduce the need for medica-
tion, and help maintain effects over the long term. There
is evidence that psychological treatments are effective in
reducing pain intensity in children and adolescents with
headache, and that therapies such as relaxation and cog-
nitive behavioral therapy may have lasting effect in im-
proving mood and reducing pain for chronic headache
[115]. The application of behavioral therapy in the man-
agement of headache in children and adolescents is an
effective alternative to drugs without the problematic
and dangerous side effects of pharmacological treat-
ments and the cost savings of not having to purchase
prescription or over-the-counter medications [116, 117].
Clinicians should inquire about behavioral therapy and
other non pharmacological treatments for migraine, in
order to plan an integrative approach, especially in chil-
dren and adolescents with headache.
Acknowledgements
The authors thank Miss Felicity Williams for her thorough English language
editing.
Funding
This research received no specific grant from any funding agency in the
public, commercial, or non-profit sectors.
Authors’ contributions
NF and VG conceived and designed the study. RC, PV, MA were responsible
for critical revision of this manuscript. NF, RC, PV, MA, DM and VG were
responsible for data acquisition. All authors approved the final version of this
manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Pediatrics and Child and Adolescent Neuropsychiatry,
Sapienza University of Rome, Via dei Sabelli, 108, 00185 Rome, Italy.
2Department of Dynamic and Clinical Psychology, Sapienza University of
Rome, Rome, Italy. 3Department of Computer, Control and Management
Engineering Antonio Ruberti, Sapienza University of Rome, Rome, Italy. 4Glia
Institute, Ribeirão Preto, São Paulo, Brazil.
Received: 2 July 2016 Accepted: 20 August 2016
References
1. Abu-Arafeh I (2014) Diagnosis and management of headache in children
and adolescents. Prog Neurol Psychiatry 18(4):16–20
2. Hershey AD (2012) Pediatric headache: update on recent research.
Headache 52(2):327–332
3. Lipton RB, Bigal ME (2007) Ten lessons in the epidemiology of migraine.
Headache 47(1):S2–S9
4. Powers SW, Andrasik F (2005) Biobehavioral treatment, disability, and
psychological effects of pediatric headache. Pediatr Ann 34:461–465
5. Bellini B, Arruda M, Cescut A, Saulle C, Persico A, Carotenuto M, Gatta M,
Nacinovich R, Piazza FP, Termine C, Tozzi E, Lucchese F, Guidetti V (2013)
Headache and comorbidity in children and adolescents. J Headache Pain
14:79
6. Blaauw BA, Dyb G, Hagen K, Holmen TL, Linde M, Wentzel-Larsen T,
Zwart JA (2015) The relationship of anxiety, depression and behavioral
problems with recurrent headache in late adolescence – a Young-HUNT
follow-up study. J Headache Pain 16:10
7. Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D,
Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P (2010) Psychiatric
comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr
Dis Treat 6:81–91
8. Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N,
Negro A, Simmaco M, Girardi P, Martelletti P (2012) Gene variants with
suicidal risk in a sample of subjects with chronic migraine and affective
temperamental dysregulation. Eur Rev Med Pharmacol Sci 16(10):1389–1398
9. Serafini G, Pompili M, Innamorati M, Negro A, Fiorillo M, Lamis DA, Erbuto D,
Marsibilio F, Romano A, Amore M, D’Alonzo L, Bozzao A, Girardi P,
Martelletti P (2012) White matter hyperintensities and self-reported
depression in a sample of patients with chronic headache. J Headache
Pain 13(8):661–667
10. Piccinini M, Vieno A, Santinello M (2011) Use of medicines and lifestyles
among Italian adolescents. Epidemiol Prev 35(3-4):222–228
11. Christiansen S, Jürgens TP, Klinger R (2015) Outpatient Combined Group
and Individual Cognitive-Behavioral Treatment for Patients With Migraine
and Tension-Type Headache in a Routine Clinical Setting. Headache
55(8):1072–1091
12. Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M,
Kabbouche MA, O’Brien HL, Shenk CE, Rausch JR, Hershey AD (2013)
Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine
in Children and Adolescents A Randomized Clinical Trial. Jama
310(24):2622–2630
Faedda et al. The Journal of Headache and Pain  (2016) 17:80 Page 8 of 10
13. Mazzotta G, Gallai B, Mattioni A, Floridi F, Foti F, Allegretti M, D’Angelo R
(2005) Cost assessment of headache in childhood and adolescence:
preliminary data. J Headache Pain 6(4):281–283
14. Mauskop A (2012) Nonmedication, alternative, and complementary
treatments for migraine. Continuum (Minneap Minn) 18(4):796–806
15. Weeks RE (2013) Application of behavioral therapies in adult and adolescent
patients with chronic migraine. Neurol Sci 34(1):S11–S17
16. Basler HD, Franz C, Kröner-Herwig B, Rehfisch HP (eds) (2004) Psychologische
Schmerztherapie. Springer, Berlin
17. Damen L, Bruijn J, Koes BW, Berger MY, Passchier J, Verhagen AP (2006)
Prophylactic treatment of migraine in children. Part 1. A systematic review
of non-pharmacological trials. Cephalalgia 26(4):373–383
18. Campbell JK, Penzien D, Wall EM (2000) Evidence-based guidelines for
migraine headache: behavioral and physical treatments. Neurology [serial
online] http://tools.aan.com/professionals/practice/pdfs/gl0089.pdf. Org.
Accessed 15 May 2016.
19. Penzien DB, Irby MB, Smitherman TA, Rains JC, Houle TT (2015) Well-
established and empirically supported behavioral treatments for migraine.
Curr Pain Headache Rep 19:34
20. Robbins M, Grosberg BM, Lipton R (2013) Headache. In: Gross RA, Mink JW
(eds) Neurology in Practice. Wiley-Blackwell, NY, USA. p 336
21. Rathier L, Roth J (2015) A Biobehavioral Approach to Headache
Management. In: Roth J (Ed) Headache Disorders, vol 26. Rhode Island
Med J 98(2):26–28
22. Kabbouche MA, Gilman DK (2008) Management of migraine in adolescents.
Neuropsychiatr Dis Treat 4(3):535–548
23. Powers SW, Gilman DK, Hershey AD (2006) Suggestions for a biopsychosocial
approach to treating children and adolescents who present with headache.
Headache 46(3):S149–S150
24. Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA
(2014) Treatment Adherence in Patients With Headache: A Systematic
Review. Headache 54:795–816
25. Rapoff MA (2010) Adherence to Pediatric Medical Regimens, 2nd edn.
Springer, New York
26. Winner P, Migraine (2009) Diagnosis and Treatment. In: Hershey AD,
Powers SW, Winner P, Kabbouche MA (eds), Pediatric Headaches in
Clinical Practice. John Wiley & Sons, Oxford. p 83–95
27. Grazzi L, Andrasik F, Usai S, D’Amico D, Bussone G (2004) Pharmacological
behavioural treatment for children and adolescents with tension-type
headache: Preliminary data. Neurol Sci 25(3):S270–S271
28. Andrasik F, Grazzi L, Usai S, Bussone G (2007) Pharmacological treatment
compared to behavioural treatment for juvenile tension-type headache:
Results at two-year follow-up. Neurol Sci 28(2):S235–S238
29. Allen KD, McKeen LR (1991) Home-based multicomponent treatment of
pediatric migraine. Headache 31:467–472
30. Engel JM (1993) Children’s compliance with progressive relaxation procedures
for improving headache control. OTJR (Thorofare N J) 13:19–230
31. Drotar D (ed) (2000) Promoting Adherence to Medical Treatment in Chronic
Childhood Illness: Concepts, Methods, and Interventions. Lawrence Eribaum
Associates, Mahwah
32. Iuga AO, McGuire MJ (2014) Adherence and health care costs. Risk Manag
Healthc Policy 7:35–44
33. LaGreca AM, Schuman WB (1995) Adherence to prescribed medical
regimens. In: Roberts MC (ed) Handbook of Pediatric Psychology. Guilford,
New York, pp 55–83
34. Taddeo D, Egedy M, Frappier JY (2008) Adherence to treatment in adolescents.
Paediatr Child Health 13(1):19–24
35. Becker WJ, Gladstone JP, Aube M (2007) Migraine prevalence, diagnosis and
disability. Can J Neurol Sci 34(4):S3–S9
36. Craddock L, Lynne DR (2012) Pediatric migraine teaching for families. J Spec
Pediatr Nurs 17(2):98–107
37. Antonaci F, Sances G, Guaschino E, De Cillis I, Bono G, Nappi G (2008)
Meeting patient expectations in migraine treatment: What are the key
endpoints? J Headache Pain 9:207–213
38. Labos C (2015) Lifestyle Interventions: The Best Medicine You’re Not Using.
http://www.medscape.com/viewarticle/843028. Accessed 17 May 2016
39. Zebenholzer K, Frantal S, Pablik E, Lieba-Samal D, Salhofer-Polanyi S, Wöber-Bingöl
Ç, Wöber C (2016) Reliability of assessing lifestyle and trigger factors in patients
with migraine - findings from the PAMINA study. Eur J Neurol 23(1):120–126
40. Chakravarty A, Mukherjee A, Roy D (2009) Trigger factors in childhood migraine:
a clinic-based study from eastern India. J Headache Pain 10(5):375–380
41. Neut D, Fily A, Cuvellier JC, Vallée L (2012) The prevalence of triggers in
paediatric migraine: a questionnaire study in 102 children and adolescents.
J Headache Pain 13(1):61–65
42. Fraga MD, Pinho RS, Andreoni S, Vitalle MS, Fisberg M, Peres MF,
Vilanova LC, Masruha MR (2013) Trigger factors mainly from the
environmental type are reported by adolescents with migraine. Arq
Neuropsiquiatr 71(5):290–293
43. Dosi C, Figura M, Ferri R, Bruni O (2015) Sleep and Headache. Semin Pediatr
Neurol 22(2):105–112
44. Freedom T (2015) Headaches and sleep disorders. Dis Mon 61(6):240–248
45. Jennum P, Jensen R (2002) Sleep and headache. Sleep Med Rev
6(6):471–479
46. Bruni O, Galli F, Guidetti V (1999) Sleep hygiene and migraine in children
and adolescents. Cephalalgia 19(25):57–59
47. Connelly M, Miller T, Gerry G, Bickel J (2010) Electronic momentary
assessment of weather changes as a trigger of headaches in children.
Headache 50(5):779–789
48. Powers SW, Hershey AD, Coffey CS, Chamberlin LA, Ecklund DJ, Sullivan SM,
Klingner EA, Yankey JW, Kashikar-Zuck S, Korbee LL, Costigan ML, Riss HH,
Porter LL (2016) The Childhood and Adolescent Migraine Prevention
(CHAMP) Study: A Report on Baseline Characteristics of Participants.
Headache doi: 10.1111/head.12810 [Epub ahead of print]
49. Corletto E, Dal Zotto L, Resos A, Tripoli E, Zanchin G, Bulfoni C,
Battistella PA (2008) Osmophobia in juvenile primary headaches.
Cephalalgia 28(8):825–831
50. Connelly M, Bickel J (2011) An electronic daily diary process study of stress
and health behavior triggers of primary headaches in children. J Pediatr
Psychol 36(8):852–862
51. Esposito M, Ruberto M, Pascotto A, Carotenuto M (2012) Nutraceutical
preparations in childhood migraine prophylaxis: effects on headache
outcomes including disability and behaviour. Neurol Sci 33(6):1365–1368
52. Jacobs H, Gladstein J (2012) Pediatric headache: a clinical review. Headache
52(2):333–339
53. Menon S, Lea RA, Ingle S, Sutherland M, Wee S, Haupt LM, Palmer M,
Griffiths LR (2015) Effects of dietary folate intake on migraine disability and
frequency. Headache 55(2):301–309
54. Cayir A, Turan MI, Tan H (2014) Effect of vitamin D therapy in addition to
amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res
47(4):349–354
55. Talebi M, Savadi-Oskouei D, Farhoudi M, Mohammadzade S,
Ghaemmaghamihezaveh S, Hasani A, Hamdi A (2011) Relation between
serum magnesium level and migraine attacks. Neurosciences (Riyadh)
16(4):320–323
56. Patniyot IR, Gelfand AA (2016) Acute Treatment Therapies for Pediatric
Migraine: A Qualitative Systematic Review. Headache Jan 56(1):49–70
57. O’Brien HL, Hershey AD (2010) Vitamins and paediatric migraine: Riboflavin
as a preventative medication. Cephalalgia 30(12):1417–1418
58. O’Brien HL, Kabbouche MA, Kacperski J, Hershey AD (2015) Treatment of
Pediatric Migraine. Curr Treat Options Neurol 17:1
59. Usai S, Grazzi L, Bussone G (2011) Ginkolide B as migraine preventative
treatment in young age; results at 1-year follow-up. Neurol Sci
32(1):S197–S199
60. Sun-Edelstein C, Mauskop A (2009) Foods and supplements in the
management of migraine headaches. Clin J Pain 25(5):446–452
61. Tepper SJ (2008) Complementary and alternative treatments for childhood
headaches. Curr Pain Headache Rep 12(5):379–383
62. Betteridge DJ (2000) What is oxidative stress? Metabolism 49(2 Suppl 1):3–8
63. Boćkowski L, Sobaniec W, Kułak W, Smigielska-Kuzia J (2008) Serum and
intraerythrocyte antioxidant enzymes and lipid peroxides in children with
migraine. J Pharmacol Rep 60(4):542–548
64. Eidlitz-Markus T, Haimi-Cohen Y, Steier D, Zeharia A (2010) Effectiveness of
nonpharmacologic treatment for migraine in young children. Headache
50(2):219–223
65. Sieberg CB, Huguet A, von Baeyer CL, Seshia S (2012) Psychological
interventions for headache in children and adolescents. Can J Neurol Sci
39(1):26–34
66. Rains JC, Penzien DB, McCrory DC, Gray RN (2005) Behavioral headache
treatment: history, review of the empirical literature, and methodological
critique. Headache 45(2):S92–S109
67. Ehde MD, Dillworth MT, Turner JA (2014) Cognitive-Behavioral Therapy for
Individuals With Chronic Pain. Am Psychol Assoc 69(2):153–166
Faedda et al. The Journal of Headache and Pain  (2016) 17:80 Page 9 of 10
68. Andrasik F (2003) Behavioral treatment approaches to chronic headache.
Neurol Sci 24(2):S80–S85
69. French DJ, Holroyd KA, Pinell C, Malinoski PT, O’Donnell F, Hill KR (2000)
Perceived self-efficacy and headache-related disability. Headache
40(8):647–656
70. Penzien DB, Taylor FR (2014) Headache toolbox. Behavioral and other
nonpharmacologic treatments for headache. Headache 54(5):955–956
71. Chiappedi M, Mensi MM, Termine C, Balottin U (2016) Psychological Therapy
in Adolescents with Chronic Daily Headache. Curr Pain Headache Rep
20(1):3
72. Sieberg RGJ, McGrath PJ (1996) Psychological treatments for migraine.
Biomed Pharmacother 50(2):58–63
73. Engel JM, Rapoff MA, Pressman AR (1992) Long-term follow-up of relaxation
training for pediatric headache disorders. Headache 32(3):152–156
74. Powers SW, Hershey AD (2002) Biofeedback for childhood migraine. In:
Maria BL (ed) Current Management in Child Neurology. BC Decker, Inc,
Hamilton, pp 83–85
75. Mullally WJ, Hall K, Goldstein R (2009) Efficacy of biofeedback in the
treatment of migraine and tension type headaches. Pain Physician
12(6):1005–1011
76. Balottin U, Ferri M, Racca M, Rossi M, Rossi G, Beghi E, Chiappedi M,
Termine C (2014) Psychotherapy versus usual care in pediatric migraine and
tension-type headache: a single-blind controlled pilot study. Ital J Pediatr 40:6
77. Kröner-Herwig B (2014) Headache in children and adolescents. Epidemiology,
biopsychosocial correlates, and psychological treatment approaches.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
57(8):928–934
78. Holroyd KA, Cottrell CK, O’Donnell FJ, Cordingley GE, Drew JB, Carlson BW,
Himawan L (2010) Effect of preventive (beta blocker) treatment, behavioural
migraine management, or their combination on outcomes of optimised acute
treatment in frequent migraine: randomised controlled trial. BMJ 341:c4871
79. Levine M (2008) Comprehensive Review of Headache Medicine, Oxford
University Press. p 336
80. Kandel ER (1998) A new intellectual framework for psychiatry. J Psychiatry
155(4):457–469
81. Gabbard GO (2000) A neurobiologically informed perspective on
psychotherapy. Br J Psychiatry 177:117–122
82. Mayford M, Siegelbaum SA, Kandel ER (2012) Synapses and memory
storage. Cold Spring Harb Perspect Biol. 4(6)
83. Beauregard M (2014) Functional neuroimaging studies of the effects of
psychotherapy. Dialogues Clin Neurosci 16(1):75–81
84. Janiri L, Guglielmo R, Bruschi A (2009) Psicoterapia e neuroscienze:
l'integrazione possibile. Modelli per la mente, 2(2):7-13
85. Mundo E (2006) Neurobiology of dynamic psychotherapy: an integration
possible? J Am Acad Psychoanal Dyn Psychiatry 34(4):679–691
86. Karlsson H (2011) How Psychotherapy Changes the Brain. Psychiatric Times
28(8). http://www.psychiatrictimes.com/psychotherapy/how-psychotherapy-
changes-brain.Accessed 27 April 2016
87. Frewen PA, Dozois DJ, Lanius RA (2008) Neuroimaging studies of
psychological interventions for mood and anxiety disorders: empirical and
methodological review. Clin Psychol Rev 28(2):228–246
88. Bennett S, Shafran R, Coughtrey A, Walker S, Heyman I (2015) Psychological
interventions for mental health disorders in children with chronic physical
illness: a systematic review. Arch Dis Child 100:308–316
89. Cousins S, Ridsdale L, Goldstein LH, Noble AJ, Moorey S, Seed P (2015) A
pilot study of cognitive behavioural therapy and relaxation for migraine
headache: a randomised controlled trial. J Neurol 262(12):2764–2772
90. Fisher E, Heathcote L, Palermo TM, Williams AC, Lau J, Eccleston C (2014)
Systematic Review and Meta-Analysis of Psychological Therapies for
Children With Chronic Pain. J Pediatr Psychol 39(8):763–782
91. Holroyd KA (2002) Assessment and psychological management of recurrent
headache disorders. J Consult Clin Psych 70:656–677
92. Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of
recurrent headache: Three decades of experience and empiricism. Appl
Psychophysiol Biofeedback 27:163–181
93. Andrasik F (2007) What does the evidence show? Efficacy of behavioural
treatments for recurrent headaches in adults. Neurol Sci 28:70–77
94. Chen YZ, Li N, Zhou KY (2014) Preventive effect of behavioral therapy plus
flunarizine in children with migraine. Zhongguo Dang Dai Er Ke Za Zhi
16(11):1105–1108
95. Eccleston C, Yorke L, Morley S, Williams AC, Mastroyannopoulou K (2003)
Psychological therapies for the management of chronic and recurrent
pain in children and adolescents. Cochrane Database Syst Rev 1,
CD003968
96. Kohen DP (2010) Long-term follow-up of self-hypnosis training for recurrent
headaches: what the children say. Int J Clin Exp Hypn 58(4):417–432
97. Sierpina V, Astin J, Giordano J (2007) Mind-body therapies for headache. Am
Fam Physician 76(10):1518–1522
98. Olness K, MacDonald JT, Uden DL (1987) Comparison of self-hypnosis and
propranolol in the treatment of juvenile classic migraine. Pediatrics
79(4):593–597
99. Kohen DP (2011) Chronic daily headache: helping adolescents help
themselves with self-hypnosis. Am J Clin Hypn 54(1):32–46
100. Trautmann E, Lackschewitz H, Kröner-Herwig B (2006) Psychological
treatment of recurrent headache in children and adolescents—a meta-
analysis. Cephalalgia 26(12):1411–1426
101. Kropp P, Meyer B, Landgraf M, Ruscheweyh R, Ebinger F, Straube A (2013)
Headache in children: update on biobehavioral treatments. Neuropediatrics
44(1):20–24
102. Andrasik F (1996) Behavioral management of migraine. Biomed Pharmacother
50(2):52–57
103. Blume HK, Brockman LN, Breuner CC (2012) Biofeedback therapy for pediatric
headache: factors associated with response. Headache 52(9):1377–1386
104. Palermo TM, Eccleston C, Lewandowski AS, Williams AC, Morley S (2010)
Randomized controlled trials of psychological therapies for management of
chronic pain in children and adolescents: an updated meta-analytic review.
Pain 148(3):387–397
105. Fisher E, Law E, Palermo TM, Eccleston C (2010) Psychological therapy
(remotely delivered) for the management of chronic pain and recurrent
pain in Ch and Adol. Cochrane Database System, 2015 combination on
outcomes of optimised acute treatment in frequent migraine: randomised
controlled trial. BMJ 341:c4871
106. Silberstein SD (2000) Practice parameter: evidence-based guidelines for
migraine headache (an evidence-based review) report of the Quality
Standards Subcommittee of the American Academy of Neurology.
Neurology 55(6):754–762
107. Penzien DB, Irby MB (2014) Insights on treatment mechanisms of cognitive-
behavioral migraine therapy. Headache 54(9):1439–1440
108. Goldfriend MR, Castonguay LG (1993) Behavior Therapy: Redefining
Strenghts and Limitations. Behav Ther 24:505–S26
109. Wright JH, Davis D (1994) The Therapeutic Relationship in Cognitive-
Behavioral Therapy: Patient Perceptions and Therapist Responses. Cogn
Behav Pract 1:25–45
110. Kropf P, Greene RR (2012) Cognitive and Behavioral Approaches: In Kropf P,
Greene RR, Competence: Theoretical Frameworks. Aldine Transaction,
Transaction Publishers, New Brunswick, NewJersey, 232 pp
111. Leahy RL (2006) A Relational Approach to Negotiating Alliance Ruptures. In:
Leahy RL, Roadblocks in Cognitive-Behavioral Therapy: Transforming
Challenges Into Opportunities for Change. Guilford Press, New York. pp 364
112. Kennard J (2014) Benefits and Limitations of Cognitive Behavioral Therapy
(CBT) for Treating Anxiety. http://www.healthcentral.com/anxiety/c/4182/
165578/benefits-limitations-treating/. Accessed 20 May 2016.
113. Rains JC, Penzien DB (2005) Behavioral research and the double-blind
placebo-controlled methodology: challenges in applying the biomedical
standard to behavioral headache research. Headache 45:479–486
114. Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C
(2011) Overview of diagnosis and management of paediatric headache.
Part II: therapeutic management. J Headache Pain 12(1):25–34
115. Health E-BC, Editorial Office (2013) Clinical Answers: Are nonpharmacological
interventions for migraine effective in children and Adolescents. Evid-Based
Child Health 8:754–758
116. Grazzi L, D’Amico D, Leone M, Moschiano F, Bussone G (1998) Pharmacological
and behavioral treatment of pediatric migraine and tension-type headache. Ital
J Neurol Sci 19(2):59–64
117. Kohen DP, Zajac R (2007) Self-hypnosis training for headaches in children
and adolescents. J Pediatr 150(6):635–639
Faedda et al. The Journal of Headache and Pain  (2016) 17:80 Page 10 of 10
